News

Prescribed use of anti-anxiety drugs, hypnotics and sedatives, or antidepressants was tied to a higher future risk of ...
Brad G. Smith, an ALS patient, regains communication abilities with a Neuralink implant, illustrating the potential of ...
As part of ALS Awareness Month, the Miami Marlins recognized Lou Gehrig’s legacy and the fight against ALS during a special ...
The Everylife Foundation for Rare Diseases is offering a new scholarship for U.S. students from the ALS community facing ...
Analysts at Truist Securities called the mid-stage data a "mixed bag," also flagging gastrointestinal adverse events. However ...
Monday marked the annual Lou Gehrig Day, which took place on June 1-2 this year and raises awareness about ALS (Amyotrophic ...
Guest writer Nancy Muirhead recalls the awkward conversation she had with friends following a devastating ALS diagnosis. Then ...
The FDA has granted fast-track designation to an investigational antisense oligonucleotide that targets a specific driver of ...
UC Irvine researchers conducted a study to better understand the molecular basis of amyotrophic lateral sclerosis (ALS), a ...
Experts predict cases will rise by 2030, affecting hundreds of Michigan families battling the fatal condition.
Michigan demands ALS case reporting to enhance disease monitoring and research, aiming for a brighter future for patients.
Corcept Therapeutics has tried to cast its recent phase 2 amyotrophic lateral sclerosis (ALS) failure in a more flattering ...